BIOROBOOST

BioRoboost is an international collaborative network on synthetic biology standards. Synthetic biology is an engineering research field aiming at (re)designing biological circuits for applied purposes. As any other engineering field, it strongly relies on the use of well-defined, universal and robust standard components. Nevertheless, there are both historical and technical difficulties to reach this ambitious goal. BioRoboost aims to overcome the difficulties in the standardisation of synthetic biology through a series of different actions and activities, including: the definition of consensus and building a reference on standardisation, the organization of networking and workshop events, the communication with industry and stakeholders, and the analysis of societal ramifications and cultural reactions to standardized biology.

  • BioRoboost is a Coordination Support Action (CSA) project that has received funding from the European Union’s Horizon 2020.
  • The project is led and coordinated by the Universitat de València. It began on the 1st October 2018, and finished on the 30th September 2021.
  • The BioRoboost consortium is composed of a unique combination of 27 prime research laboratories, social scientists, companies and biotech-related experts from Europe, Asia and the US (21 European entities and 6 non-European).

 

BioRoboost has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N820699.

PROJECT PARTNERS
  • Universitat de Valencia (Spain)
  • Biofaction KG (Austria)
  • Fundacio Centre de Regulacio Genomica (Spain)
  • Agencia Estatal Consejo Superior Deinvestigaciones Cientificas (Spain)
  • Darwin Bioprospecting Excellence (Spain)
  • Danmarks Tekniske Universitet (Denmark)
  • The University of Edinburgh (UK)
  • European Molecular Biology Organization (Switzerland)
  • Eidgenoessische Technische Hochschule Zuerich (Switzerland)
  • Explora Srl (Italy)
  • Institut National de la Recherche Agronomique (France)
  • Universiteit Gent (Belgium)
  • Imperial College of Science Technology and Medicine (UK)
  • Kemijski Institut (Slovenia)
  • Philipps Universitaet Marburg (Germany)
  • University of Newcastle upon Tyne (UK)
  • Panepistimio Thessalias (Greece)
  • Universitetet I Oslo (Norway)
  • Asociacion Espanola de Normalizacion (Spain)
  • The University of Warwick (UK)
  • Max Planck Institute for Terrestrial Microbiology (Germany)
  • Tsinghua University (China)
  • Ginkgo Bioworks, Inc. (US)
  • University of Washington (US)
  • Waseda University (Japan)
  • Board of Trustees of the Leland Stanford Junior University (US)
  • National University of Singapore (Singapore)
BIOFACTION'S ROLE

Biofaction worked on ways to enhance biosafety and risk assessment in synthetic biology standards.